BCAX affiliate files Form 144 to sell 50,000 shares

BCAX affiliate filed a Form 144 to offer 50,000 shares.

Accepted by SEC EDGAR 06/25/2026 - 04:07 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

BCAX affiliate filed a Form 144 to offer 50,000 shares. The filing lists the method as a stock option exercise to be settled for cash and shows an aggregate offering value of $1,324,650.00. The filing also reports prior sales of 5,500 shares on 05/26/2026 and 5,500 shares on 04/27/2026.

Insights

Securities Attorney

Form 144 notifies market of an affiliate's planned resale under Rule 144.

The notice states 50,000 shares will be sold following a stock option exercise for cash. The filing includes an aggregate value of $1,324,650.00 and an outstanding share figure of 65,703,866 reported in the excerpt.

Past sales by the reporting affiliate totaled 5,500 shares on 05/26/2026 and 5,500 shares on 04/27/2026. Timing and exact distribution methods beyond "cash" are not detailed in the excerpt; subsequent filings would show completed transactions.

Key Figures

Shares to be offered: 50,000 shares Aggregate offering value: $1,324,650.00 Shares outstanding (excerpt): 65,703,866 +2 more

5 metrics

Shares to be offered 50,000 shares Form 144 securities to be sold, <date>06/25/2026</date>

Aggregate offering value $1,324,650.00 Listed in securities information block

Shares outstanding (excerpt) 65,703,866 Securities information line in the excerpt

Prior sale 1 5,500 shares Sold on <date>05/26/2026</date> for <money>$118,737.85</money>

Prior sale 2 5,500 shares Sold on <date>04/27/2026</date> for <money>$125,830.01</money>

Key Terms

Form 144, Rule 144, Stock Option Exercise

3 terms

Form 144 regulatory

"144: Securities To Be Sold"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Rule 144 regulatory

"144: Filer Information"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Stock Option Exercise financial

"Common | 06/25/2026 | Stock Option Exercise"

A stock option exercise is the act of using a previously granted right to buy shares of a company's stock at a specific, predetermined price by paying that price and receiving the shares. It matters to investors because exercising changes who owns the shares (which can dilute existing ownership), can trigger taxable events and shift potential gains or losses, and affects voting power and the company’s outstanding share count—like turning a voucher into an actual product that becomes part of circulating supply.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does BCAX's Form 144 filing mean for shareholders?

It notifies the market that an affiliate plans to offer 50,000 shares following a stock option exercise. The filing lists an aggregate value of $1,324,650.00 and does not specify further distribution mechanics.

How many shares did the affiliate previously sell according to the Form 144?

The filing reports prior disposals of 5,500 shares on 05/26/2026 for $118,737.85 and 5,500 shares on 04/27/2026 for $125,830.01. These are listed as past sales in the excerpt.

What sale method does BCAX's Form 144 list for the 50,000 shares?

The excerpt specifies the shares result from a stock option exercise and the settlement method is stated as cash. No further distribution channels or underwriting details are provided in the excerpt.

Does the Form 144 show BCAX's outstanding share count?

The excerpt includes a number of 65,703,866, which appears alongside other securities information. The filing text in the excerpt does not label that number further; it is shown in the securities information block.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002034679
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	BICARA THERAPEUTICS INC.
SEC File Number	001-42271
Address of Issuer	116 Huntington Ave Suite 703 Boston MASSACHUSETTS 02116
Phone	617-468-4219
Name of Person for Whose Account the Securities are To Be Sold	DAVID RABEN
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	50000	1324650.00	65703866	06/25/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/25/2026	Stock Option Exercise	Issuer			50000	06/25/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
David Raben 116 Huntington Ave Suite 703 Boston MA 02116	Common	05/26/2026	5500	118737.85
David Raben 116 Huntington Ave Suite 703 Boston MA 02116	Common	04/27/2026	5500	125830.01

144: Remarks and Signature

Remarks
Date of Notice	06/25/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ David Raben
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)